Wolfs On Wallstreet
  • Economy
  • Investing
  • Stock
  • Editor’s Pick
Stock

Juul e-cigarette ban: here’s what former FDA boss Dr Gottlieb has to say

by June 23, 2022
written by June 23, 2022

Juul Labs is in focus on Thursday after the Food and Drug Administration barred it from selling its e-cigarettes in the United States.

Former FDA commissioner reacts to the news on CNBC

Yet, e-cigarettes from rivals RJ Reynolds, NJOY, and Logic remain authorised for sale in the U.S. Explaining why on CNBC’s “Squawk Box”, former FDA commissioner Dr Scott Gottlieb said:

I think the issue with Juul Labs device is the legacy of youth addiction with that product and that the fact that it was inappropriately marketed to children and became the fulcrum of the youth addiction crisis.

Shares of Altria Group Inc (NYSE: MO) that has a 35% stake in Juul Labs have been sinking in recent hours. The decision sure is a big blow to the e-cigarettes maker that dubs U.S. its largest market.

Dr Gottlieb was behind FDA’s initial push to regulate nicotine

The announcement comes as part of the regulator’s broader push to regulate the vaping industry. Dr Gottlieb was behind the initial framework created to regulate nicotine levels in 2017.

What they’re doing right now is following the framework we put forward in summer 2017. It was a multi-part plan to regulate nicotine in the combustible products but open up avenues for the non-combustible products. They’ve done that.

Juul’s mint and fruit flavoured vapes were already banned in the U.S. in 2020. The FDA also wants tobacco companies to cut nicotine content in their products to minimally or non-addictive levels.

The post Juul e-cigarette ban: here’s what former FDA boss Dr Gottlieb has to say appeared first on Invezz.

0 comment
0
FacebookTwitterPinterestEmail

previous post
Bad Explanations for Inflation
next post
Adam Seessel: ‘Amazon is an inevitable stock for the next 10 to 15 years’

You may also like

Dow Jones, the S&P 500, and Nasdaq price...

June 26, 2022

Expert on Bath & Body Works: ‘an easy...

June 26, 2022

Should I buy CrowdStrike shares after a positive...

June 25, 2022

Why Nvidia Corporation may decline to $130 before...

June 25, 2022

Dell Technologies is entering a price consolidation phase

June 25, 2022

CF Industries is the best buy among the...

June 25, 2022

Kellogg stock gains 5%: management announces business split

June 25, 2022

Mondelez International is making this $2.9 billion acquisition

June 25, 2022

Twitter partners with Shopify as it forays into...

June 25, 2022

Ocean Biochem shares up 110% after announcing merger...

June 25, 2022
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

  • Dow Jones, the S&P 500, and Nasdaq price forecast after last week’s gain
  • Tribalism’s Big Lie
  • The Lineaments of the Ancient Constitution
  • Expert on Bath & Body Works: ‘an easy double the next three years’
  • Should I buy CrowdStrike shares after a positive view from Morgan Stanley?

Latest Articles

  • Dow Jones, the S&P 500, and Nasdaq price forecast after last week’s gain

    June 26, 2022
  • Tribalism’s Big Lie

    June 26, 2022
  • The Lineaments of the Ancient Constitution

    June 26, 2022
  • Expert on Bath & Body Works: ‘an easy double the next three years’

    June 26, 2022
  • Should I buy CrowdStrike shares after a positive view from Morgan Stanley?

    June 25, 2022
  • Why Nvidia Corporation may decline to $130 before rallying

    June 25, 2022
  • CF Industries is the best buy among the fertilizer manufacturers

    June 25, 2022

Categories

  • Economy (1,062)
  • Editor's Pick (590)
  • Investing (281)
  • Stock (1,516)
About Us Terms & Conditions Privacy Policy Email WhiteListing Contact Us

Disclaimer: Wolfsonwallstreet.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 WolfSonWallstreet.com


Back To Top
Wolfs On Wallstreet
  • Economy
  • Investing
  • Stock
  • Editor’s Pick